Results 191 to 200 of about 25,487 (235)

The Impact of Onchocerciasis Elimination Measures in Africa: A Systematic Review. [PDF]

open access: yesTrop Med Infect Dis
Ncogo P   +6 more
europepmc   +1 more source

Intestinal myiasis caused by Clogmia albipunctata in Nepal: a case report. [PDF]

open access: yesJ Med Case Rep
Chalise BS   +6 more
europepmc   +1 more source

Pharmacology of ivermectin [PDF]

open access: possibleParasitology Today, 1988
Ivermectin is a semi-synthetic macrocyclic lactone (Fig. I) active in single low doses against many parasites - particularly nematodes and arthropods. It has been registered for animal health use since early 1985, and was earlier this year approved for human use by the French Directorate o f Pharmacy and Drugs.
James L. Bennett, J.F. Williams, V. Dave
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Ivermectin

Dermatologic Clinics, 2003
Ivermectin is a potent antiparasitic drug and the first commercially available member of a new class of drugs (macrocyclic lactones) that has been approved for human use. Ivermectin has already proven to be highly effective in the elimination of river blindness as a public health burden.
George W, Elgart, Terri L, Meinking
openaire   +2 more sources

Home - About - Disclaimer - Privacy